Patents Assigned to Sinopharm A-think Pharmaceutical Co., Ltd
  • Histone deacetylase inhibitor of benzamides and use thereof
    Patent number: 9040727
    Abstract: Disclosed in the present invention is a novel histone deacetylase inhibitor of benzamides and use thereof. The inhibitor has good efficacy in treating diseases caused by abnormal gene expression, such as tumors, endocrine disorders, immune system diseases, genetic diseases and nerve system diseases. The histone deacetylase inhibitor of benzamides is a compound of the following general chemical structural formula (I) or a salt thereof.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: May 26, 2015
    Assignees: Shanghai Institute of Pharmaceutical Industry, Sinopharm A-Think Pharmaceutical Co., Ltd., Sinopharm A-Think Medical and Pharmaceutical Research & Development (Beijing) Co., Ltd.
    Inventors: Jianqi Li, Qingwei Zhang, Zhidan Jia, Jiajing Wang
  • NOVEL HISTONE DEACETYLASE INHIBITOR OF BENZAMIDES AND USE THEREOF
    Publication number: 20140221431
    Abstract: Disclosed in the present invention is a novel histone deacetylase inhibitor of benzamides and use thereof. The inhibitor has good efficacy in treating diseases caused by abnormal gene expression, such as tumours, endocrine disorders, immune system diseases, genetic diseases and nerve system diseases. The histone deacetylase inhibitor of benzamides is a compound of the following general chemical structural formula (I) or a salt thereof.
    Type: Application
    Filed: June 26, 2012
    Publication date: August 7, 2014
    Applicants: Shanghai Institute of Pharmaceutical Industry, Sinopharm A-think Pharmaceutical Co., Ltd
    Inventors: Jianqi Li, Qingwei Zhang, Zhidan Jia, Jiajing Wang